73 related articles for article (PubMed ID: 35242673)
1. Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer.
Shi JY; Che X; Wen R; Hou SJ; Xi YJ; Feng YQ; Wang LX; Liu SJ; Lv WH; Zhang YF
World J Clin Oncol; 2024 Mar; 15(3):391-410. PubMed ID: 38576597
[TBL] [Abstract][Full Text] [Related]
2. Tumour mutation burden and infiltrating immune cell subtypes influenced the breast cancer prognosis.
Li J; Liu H; Han M; Jiang H; He J; Miao J; Liu Y
Transl Cancer Res; 2024 May; 13(5):2208-2221. PubMed ID: 38881919
[TBL] [Abstract][Full Text] [Related]
3. Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis.
Yin L; Zhou L; Xu R
Front Mol Biosci; 2020; 7():599142. PubMed ID: 33681288
[TBL] [Abstract][Full Text] [Related]
4. Identification of tumor mutation burden-related hub genes and the underlying mechanism in melanoma.
Zhang C; Dang D; Liu C; Wang Y; Cong X
J Cancer; 2021; 12(8):2440-2449. PubMed ID: 33758620
[No Abstract] [Full Text] [Related]
5. Spatial heterogeneity and organization of tumor mutation burden with immune infiltrates within tumors based on whole slide images correlated with patient survival in bladder cancer.
Xu H; Clemenceau JR; Park S; Choi J; Lee SH; Hwang TH
J Pathol Inform; 2022; 13():100105. PubMed ID: 36268064
[TBL] [Abstract][Full Text] [Related]
6. Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma.
Liu N; Liu Z; Liu X; Duan X; Huang Y; Jin Z; Niu Y; Zhang L; Chen H
Front Genet; 2020; 11():1002. PubMed ID: 33005180
[TBL] [Abstract][Full Text] [Related]
7. Identification of New Therapeutic Targets for Gastric Cancer With Bioinformatics.
Li Y; Wang JS; Zhang T; Wang HC; Li LP
Front Genet; 2020; 11():865. PubMed ID: 33014013
[TBL] [Abstract][Full Text] [Related]
8. DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB.
Wang X; Chi W; Ma Y; Zhang Q; Xue J; Shao ZM; Xiu B; Wu J; Chi Y
Transl Oncol; 2024 Aug; 46():102016. PubMed ID: 38843658
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes.
Teng X; Yang T; Yuan B; Yang Y; Liu J; Wang X; Wang Y; Ma T; Yin X; Yu H; Wang S; Huang W
Front Oncol; 2023; 13():1177133. PubMed ID: 37350936
[TBL] [Abstract][Full Text] [Related]
10. Immune repertoire and responses to neoadjuvant TCHP therapy in HER2-positive breast cancer.
Shin J; Ham B; Seo JH; Lee SB; Park IA; Gong G; Kim SB; Lee HJ
Ther Adv Med Oncol; 2023; 15():17588359231157654. PubMed ID: 36865681
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
Ke L; Li S; Cui H
BMC Cancer; 2022 Nov; 22(1):1185. PubMed ID: 36397030
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
Yin W; Jiang X; Tan J; Xin Z; Zhou Q; Zhan C; Fu X; Wu Z; Guo Y; Jiang Z; Ren C; Tang G
Front Oncol; 2020; 10():1409. PubMed ID: 32974146
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
[TBL] [Abstract][Full Text] [Related]
14. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
Front Genet; 2021; 12():623424. PubMed ID: 33664769
[TBL] [Abstract][Full Text] [Related]
15. Identifying
Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
PeerJ; 2023; 11():e16618. PubMed ID: 38099311
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor mutation burden and the relationship between tumor mutation burden and immune infiltration in
Wen Y; Ouyang D; Chen Q; Zeng L; Luo N; He H; Anwar M; Qu L; Zou Q; Yi W
Gland Surg; 2022 Jan; 11(1):100-114. PubMed ID: 35242673
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Zhang C; Li Z; Qi F; Hu X; Luo J
Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
